Homo sapiens Protein: GUSB | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-18416.6 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | GUSB | ||||||||||||||||||
Protein Name | glucuronidase, beta | ||||||||||||||||||
Synonyms | BG; MPS7; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000302728 | ||||||||||||||||||
InnateDB Gene | IDBG-18414 (GUSB) | ||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Plays an important role in the degradation of dermatan and keratan sulfates. | ||||||||||||||||||
Subcellular Localization | Lysosome. | ||||||||||||||||||
Disease Associations | Mucopolysaccharidosis 7 (MPS7) [MIM:253220]: An autosomal recessive lysosomal storage disease characterized by inability to degrade glucuronic acid-containing glycosaminoglycans. The phenotype is highly variable, ranging from severe lethal hydrops fetalis to mild forms with survival into adulthood. Most patients with the intermediate phenotype show hepatomegaly, skeletal anomalies, coarse facies, and variable degrees of mental impairment. {ECO:0000269PubMed:12522561, ECO:0000269PubMed:12859417, ECO:0000269PubMed:1702266, ECO:0000269PubMed:7573038, ECO:0000269PubMed:7633414, ECO:0000269PubMed:7680524, ECO:0000269PubMed:8089138, ECO:0000269PubMed:8111412, ECO:0000269PubMed:8111413, ECO:0000269PubMed:8644704, ECO:0000269PubMed:8707294, ECO:0000269PubMed:9099834, ECO:0000269PubMed:9490302}. Note=The disease is caused by mutations affecting the gene represented in this entry.Note=Mucopolysaccharidosis type 7 is associated with non- immune hydrops fetalis, a generalized edema of the fetus with fluid accumulation in the body cavities due to non-immune causes. Non-immune hydrops fetalis is not a diagnosis in itself but a symptom, a feature of many genetic disorders, and the end-stage of a wide variety of disorders. | ||||||||||||||||||
Tissue Specificity | |||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 8 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR006101
Glycoside hydrolase, family 2 IPR006102 Glycoside hydrolase, family 2, immunoglobulin-like beta-sandwich IPR006103 Glycoside hydrolase, family 2, TIM barrel IPR006104 Glycosyl hydrolases family 2, sugar binding domain IPR008979 Galactose-binding domain-like IPR017853 Glycoside hydrolase, superfamily |
||||||||||||||||||
PFAM |
PF00703
PF02836 PF02837 |
||||||||||||||||||
PRINTS |
PR00132
|
||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART | |||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | P08236 | ||||||||||||||||||
PhosphoSite | PhosphoSite-P08236 | ||||||||||||||||||
TrEMBL | |||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 2990 | ||||||||||||||||||
UniGene | Hs.255230 | ||||||||||||||||||
RefSeq | NP_000172 | ||||||||||||||||||
HUGO | HGNC:4696 | ||||||||||||||||||
OMIM | 611499 | ||||||||||||||||||
CCDS | CCDS5530 | ||||||||||||||||||
HPRD | 02018 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AC073261 AK223406 AK303819 BC014142 CH236961 CH471140 M10618 M15182 M65002 S72462 | ||||||||||||||||||
GenPept | AAA52561 AAA52621 AAA52622 AAD14101 AAH14142 AAQ96851 BAD97126 BAG64768 EAL23740 EAX07951 | ||||||||||||||||||